Improving Patient Access to Care and Treatment Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 12, 2021)
Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
What just happenedNov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseNov 12, 2021
- Nov 1, 2022Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - Nov 15, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 12, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Nov 12, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Nov 12, 2021IntroReferralIntro-H
Introduced in House
- Nov 12, 2021IntroReferral1000
Introduced in House